インフルエンザ診断の世界市場2017-2021:POCT、分子診断...市場調査レポートについてご紹介

【英文タイトル】Global Influenza Diagnostics Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by indication
• Influenza A
• Influenza B
• Influenza C

PART 07: Market segmentation by product
• Immunodiagnostics
• Market size and forecast
• POCT
• Market size and forecast
• Molecular diagnostics
• Market size and forecast

PART 08: Market segmentation by end-users
• Hospitals and diagnostic laboratories
• Academic and research institutes
• Home care

PART 09: Geographical segmentation
• Influenza diagnostics market in Americas
• Influenza diagnostics market in EMEA
• Influenza diagnostics market in APAC

PART 10: Market drivers
• Increasing demand for POC diagnostics
• Growing demand for automation and system integration
• Climatic condition-dependent influenza diagnostic testing

PART 11: Impact of drivers

PART 12: Market challenges
• Challenges related to laboratory diagnosis for emerging influenza viruses
• Ethical issues related to pandemic influenza
• Strained laboratory budgets and lowering reimbursement affecting instrument sales

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Potential opportunities for POL
• Leasing of influenza diagnostics instruments
• Technological advancements in detection of influenza diseases

PART 15: Vendor landscape

PART 16: Key vendor analysis
• Alere
• Becton Dickinson
• bioMerieux
• Quidel
• Key companies to watch
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global influenza diagnostics market overview
Exhibit 03: Global influenza diagnostics market ($ billions)
Exhibit 04: Market analysis of influenza diagnostics market 2016
Exhibit 05: cobas Liat Influenza A/B: Features and specifications
Exhibit 06: Five forces analysis
Exhibit 07: Types of human influenza viruses
Exhibit 08: Influenza A products
Exhibit 09: Influenza A and B products
Exhibit 10: Global influenza immunodiagnostics market 2016-2021 ($ millions)
Exhibit 11: Immunodiagnostics metrics analysis
Exhibit 12: Global influenza POCT market 2016-2021 ($ billions)
Exhibit 13: Pros and cons of POCT testing
Exhibit 14: POCT metrics analysis
Exhibit 15: Global influenza molecular diagnostics market 2016-2021 ($ millions)
Exhibit 16: Molecular diagnostics metrics analysis
Exhibit 17: Global influenza diagnostics market segmentation by end-users 2015
Exhibit 18: Various types of reference measurement services
Exhibit 19: Global clinical reference laboratory services market share by service provider 2015 and 2020 (% share)
Exhibit 20: Global influenza diagnostics market by geography 2016-2021
Exhibit 21: Influenza diagnostics market in Americas overview
Exhibit 22: Influenza diagnostics market in Americas ($ billions)
Exhibit 23: Influenza diagnostics market in EMEA overview
Exhibit 24: Influenza diagnostics market in EMEA ($ millions)
Exhibit 25: Influenza diagnostics market in APAC overview
Exhibit 26: Influenza diagnostics market in APAC ($ millions)
Exhibit 27: Advantages of POC diagnostics
Exhibit 28: CLIA-waived influenza diagnostics products
Exhibit 29: Typical seasonal patterns of influenza activity in selected countries
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Leasing of influenza diagnostics instruments
Exhibit 33: Competitive structure analysis of global influenza diagnostics market 2016
Exhibit 34: Global influenza diagnostics market: Competitive landscape
Exhibit 35: Alere: Strength assessment
Exhibit 36: Alere: Strategy assessment
Exhibit 37: Alere: Opportunity assessment
Exhibit 38: Becton Dickinson: Strength assessment
Exhibit 39: Becton Dickinson: Strategy assessment
Exhibit 40: Becton Dickinson: Opportunity assessment
Exhibit 41: bioMerieux: Strength assessment
Exhibit 42: bioMerieux: Strategy assessment
Exhibit 43: bioMerieux: Opportunity assessment
Exhibit 44: Quidel: Strength assessment
Exhibit 45: Quidel: Strategy assessment
Exhibit 46: Quidel: Opportunity assessment


【レポート販売概要】

■ タイトル:インフルエンザ診断の世界市場2017-2021:POCT、分子診断
■ 英文:Global Influenza Diagnostics Market 2017-2021
■ 発行日:2017年3月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12232
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。